NCT00328562View on ClinicalTrials.gov

ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

September 30, 2010

Conditions
Non-Small Cell Lung Carcinoma (NSCLC)
Interventions
DRUG

ZD1839 (Iressa)

RADIATION

Thoracic Radiotherapy

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER